European Pharmaceutical Review #pharma #trends

Posted On May 18 2017 by

#pharmaceutical manufacturing magazine # European Pharmaceutical Review Issues Supplements Secure your copy With every subscription, you ll get access to all past and future copies of European Pharmaceutical Review. as well as all of our exclusive online content, including the latest news, articles, webinars, videos, whitepapers, application notes, and much more! So, what are you waiting for? Advertise in this issue Want to find out about advertising opportunities in this issue? Contact us now Issue #4 2016 Here s a summary of what you ll find in the next issue of European Pharmaceutical Review: ENVIRONMENTAL MONITORING IN-DEPTH FOCUS Bacterial endotoxin …


European pharmaceutical companies #pharmaceutical #representative

Posted On May 17 2017 by

#european pharmaceutical companies # Company Our health care costs are constantly rising. This is mainly due to demographic developments, making appropriate and affordable health care increasingly difficult. We have to face this challenge to our health policies today, so that we can ensure good health care for tomorrow. Europe an opportunity. Founded in 1979, kohlpharma is now one of the leading importers of pharmaceuticals in Europe. And we remain an owner-led, independent family company to this day. Drugs are generally produced by multi-national pharmaceutical companies. These companies have varying pricing strategies within the EU, which leads to what can be …


European Medicines Agency – Partners & Networks – Pharmaceutical industry #pharmaceutical #market #size

Posted On May 17 2017 by

#european pharmaceutical companies # Pharmaceutical industry The pharmaceutical industry is one of the European Medicines Agency’s (EMA) main stakeholders. Interacting with pharmaceutical companies has been a major part of EMA’s daily business since it began operating. These interactions are guided by a formal framework that rests on the principles of accountability, transparency and broad representation. EMA routinely interacts with pharmaceutical companies through various channels, including: overseeing the centralised authorisation procedure. whereby pharmaceutical companies apply for a single marketing authorisation valid throughout the European Union (EU); providing scientific advice to companies to support research and development activities; offering targeted information to …


European Journal of Medicinal Chemistry #watson #pharma

Posted On May 12 2017 by

#drug chemistry # European Journal of Medicinal Chemistry European Journal of Medicinal Chemistry Journal Metrics Source Normalized Impact per Paper (SNIP): 1.432 ℹ Source Normalized Impact per Paper (SNIP):2015: 1.432SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field. SCImago Journal Rank (SJR): 1.184 ℹ SCImago Journal Rank (SJR):2015: 1.184SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact. Impact Factor: 3.902 ℹ …


European Medicines Agency – Partners & Networks – Pharmaceutical industry #pharmaceutical #company #list

Posted On Apr 30 2017 by

#european pharmaceutical companies # Pharmaceutical industry The pharmaceutical industry is one of the European Medicines Agency’s (EMA) main stakeholders. Interacting with pharmaceutical companies has been a major part of EMA’s daily business since it began operating. These interactions are guided by a formal framework that rests on the principles of accountability, transparency and broad representation. EMA routinely interacts with pharmaceutical companies through various channels, including: overseeing the centralised authorisation procedure. whereby pharmaceutical companies apply for a single marketing authorisation valid throughout the European Union (EU); providing scientific advice to companies to support research and development activities; offering targeted information to …


European Journal of Pharmaceutical Sciences #gw #pharma

Posted On Apr 30 2017 by

#pharmaceutical science # European Journal of Pharmaceutical Sciences The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery. The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development. More specifically, the Journal publishes reports …


European Journal of Pharmacology #pharma #business

Posted On Apr 8 2017 by

#pharmacology # European Journal of Pharmacology European Journal of Pharmacology Journal Metrics Source Normalized Impact per Paper (SNIP): 0.975 ℹ Source Normalized Impact per Paper (SNIP):2015: 0.975SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field. SCImago Journal Rank (SJR): 1.115 ℹ SCImago Journal Rank (SJR):2015: 1.115SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact. Impact Factor: 2.730 ℹ Impact Factor:2015: 2.730The …


European Journal of Medicinal Chemistry #salix #pharma

Posted On Apr 8 2017 by

#drug chemistry # European Journal of Medicinal Chemistry European Journal of Medicinal Chemistry Journal Metrics Source Normalized Impact per Paper (SNIP): 1.432 ℹ Source Normalized Impact per Paper (SNIP):2015: 1.432SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field. SCImago Journal Rank (SJR): 1.184 ℹ SCImago Journal Rank (SJR):2015: 1.184SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact. Impact Factor: 3.902 ℹ …


European pharmaceutical companies #valeant #pharma

Posted On Apr 4 2017 by

#european pharmaceutical companies # Company Our health care costs are constantly rising. This is mainly due to demographic developments, making appropriate and affordable health care increasingly difficult. We have to face this challenge to our health policies today, so that we can ensure good health care for tomorrow. Europe an opportunity. Founded in 1979, kohlpharma is now one of the leading importers of pharmaceuticals in Europe. And we remain an owner-led, independent family company to this day. Drugs are generally produced by multi-national pharmaceutical companies. These companies have varying pricing strategies within the EU, which leads to what can be …


European Medicines Agency – Partners & Networks – Pharmaceutical industry #pharma #guide

Posted On Apr 4 2017 by

#european pharmaceutical companies # Pharmaceutical industry The pharmaceutical industry is one of the European Medicines Agency’s (EMA) main stakeholders. Interacting with pharmaceutical companies has been a major part of EMA’s daily business since it began operating. These interactions are guided by a formal framework that rests on the principles of accountability, transparency and broad representation. EMA routinely interacts with pharmaceutical companies through various channels, including: overseeing the centralised authorisation procedure. whereby pharmaceutical companies apply for a single marketing authorisation valid throughout the European Union (EU); providing scientific advice to companies to support research and development activities; offering targeted information to …